Ghent University Academic Bibliography

Journal Article
A2
open access

Non-alcoholic fatty liver disease (NAFLD) in patients with psoriasis : a review of the hepatic effects of systemic therapies

Deepak Balak (UGent) , Stefano Piaserico and Ismail Kasujee

(2021) PSORIASIS-TARGETS AND THERAPY. 11. p.151-168

Journal Article
A1
open access

Effect of risankizumab on patient-reported outcomes in moderate to severe psoriasis : the UltIMMa-1 and UltIMMa-2 randomized clinical trials

Matthias Augustin, Jo Lambert (UGent) , Carla Zema, Elizabeth H. Z. Thompson, Min Yang, Eric Q. Wu, Viviana Garcia-Horton, Ziqian Geng, Joaquin M. Valdes, Avani Joshi, et al.

(2020) JAMA DERMATOLOGY. 156(12). p.1344-1353

Add to list

Journal Article
A1
open access

A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents

Inge M. G. J. Bronckers, Amy S. Paller, Dennis P. West, Irene Lara-Corrales, Megha M. Tollefson, Wynnis L. Tom, Marcia Hogeling, Leah Belazarian, Claus Zachariae, Emmanuel Mahé, et al.

(2020) JAMA DERMATOLOGY. 156(4). p.384-392

Add to list

Journal Article
A1
open access

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis

Douglas J Veale, Dennis McGonagle, Iain B McInnes, James G Krueger, Christopher T Ritchlin, Dirk Elewaut (UGent) , Keith S Kanik, Thijs Hendrikx, Gabriel Berstein, Jennifer Hodge, et al.

(2019) RHEUMATOLOGY. 58(2). p.197-205

Add to list

Secukinumab : IL-17A inhibition to treat psoriatic arthritis

Reinhart Speeckaert (UGent) , Nanja van Geel (UGent) , Jo Lambert (UGent) , L Claeys, Joris Delanghe (UGent) and Marijn Speeckaert (UGent)

(2017) DRUGS OF TODAY. 52(11). p.607-616

Add to list

Safety of systemic agents for the treatment of pediatric psoriasis

Inge MGJ Bronckers, Marieke MB Seyger, Dennis P West, Irene Lara-Corrales, Megha Tollefson, Wynnis L Tom, Marcia Hogeling, Leah Belazarian, Claus Zachariae, Emmanuel Mahé, et al.

(2017) JAMA DERMATOLOGY. 153(11). p.1147-1157

Add to list

Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis

M Augustin, C Blome, C Paul, L Puig, T Luger, Jo Lambert (UGent) , S Chimenti, G Girolomoni, K Kragballe, D Naessens, et al.

(2017) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 31(2). p.294-303

Add to list

Journal Article
A1
open access

JAK3 as an emerging target for topical treatment of inflammatory skin diseases

Ana Alves de Medeiros (UGent) , Reinhart Speeckaert (UGent) , Eline Desmet (UGent) , Mireille Van Gele (UGent) , Sofie De Schepper (UGent) and Jo Lambert (UGent)

(2016) PLOS ONE. 11(10).

Add to list

Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: what can be learnt from other diseases?

Jo Lambert (UGent) , Alexander Nast, Frank O Nestle and Jörg C Prinz

(2015) JOURNAL OF DERMATOLOGICAL TREATMENT. 26(6). p.520-527

Add to list

Treatment of spondyloarthritis beyond TNF-alpha blockade

Filip Van den Bosch (UGent) and Atul Deodhar

(2014) BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 28(5). p.819-827

Academic Bibliography

Non-alcoholic fatty liver disease (NAFLD) in patients with psoriasis : a review of the hepatic effects of systemic therapies

Effect of risankizumab on patient-reported outcomes in moderate to severe psoriasis : the UltIMMa-1 and UltIMMa-2 randomized clinical trials

A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis

Secukinumab : IL-17A inhibition to treat psoriatic arthritis

Safety of systemic agents for the treatment of pediatric psoriasis

Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis

JAK3 as an emerging target for topical treatment of inflammatory skin diseases

Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: what can be learnt from other diseases?

Treatment of spondyloarthritis beyond TNF-alpha blockade

Contents

Support

Contact